参考文献/References:
[1] Tatemoto K HM. Characterization of a novel endogenous peptide ligand for the human APJ receptor[J]. Biochem biophys Res commun, 1998, 251(2): 471-476.
[2] Kawamata Y, Habata Y, Fukusumi S, et al. Molecular properties of apelin: tissue distribution and receptor binding[J]. Biochim Biophys Acta, 2001, 1538(2/3): 162-171.
[3] O’Carroll AM, Lolait SJ, Harris LE, et al. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis[J]. J Endocrinol, 2013, 219(1):R13-35.
[4] Izgüt-Uysal VN, Gemici B, Birsen I, et al. The effect of apelin on the functions of peritoneal macrophages[J]. Physiological Research, 2017, 66(3): 489-496.
[5] Cheng B, Chen J, Bai B, et al. Neuroprotection of apelin and its signaling pathway[J]. Peptides, 2012, 37(1): 171-173.
[6] Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation[J]. Science, 1998, 281(5381): 1305-1308.
[7] Hou ST, Macmanus JP. Molecular mechanisms of cerebral ischemia-induced neuronal death[J]. Int Rev Cytol, 2002, 221(02): 93-148.
[8] Wallach D, Varfolomeev EE, Malinin NL, et al. Tumor necrosis factor receptor and Fas signaling mechanisms[J]. Annu Rev Immunol, 1999, 17: 331-367.
[9] Bao HJ, Zhang L, Han WC, et al. Apelin-13 attenuates traumatic brain Injury-Induced damage by suppressing autophagy[J]. Neurochem Res, 2015, 40(1): 89-97.
[10] 刘德胜,肖诗亮,王博,等.缺氧环境中胸腺素β4基因转染骨髓间充质干细胞凋亡率及Bax和Bcl-2的表达[J].中国组织工程研究,2014,18(41):6573-6577.
[11] Okazaki T, Magaki T, Takeda M, et al. Intravenous administration of bone marrow stromal cells increases survivin and Bcl-2 protein expression and improves sensorimotor function following ischemia in rats[J]. Neurosci Lett, 2008, 430(2): 109-114.
[12] Ayyash M, Tamimi H, Ashhab Y.Developing a powerful in silico tool for the discovery of novel caspase-3 substrates:a preliminary screening of the human proteome[Z],2012:22269041.
[13] Zq S, Dou SS, Zhu JG, et al. Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury[J]. Neural Regen Res, 2021, 16(6): 1044-1051.
[14] Yan XG, Cheng BH, Wang X, et al. Lateral intracerebroventricular injection of Apelin-13 inhibits apoptosis after cerebral ischemia/reperfusion injury[J]. Neural Regen Res, 2015, 10(5): 766-771.
[15] Aminyavari S, Zahmatkesh M, Farahmandfar M, et al. Protective role of Apelin-13 on amyloid β25-35-induced memory deficit; Involvement of autophagy and apoptosis process[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2019, 89: 322-334.
[16] Xin Q, Cheng BH, Pan YY, et al. Neuroprotective effects of apelin-13 on experimental ischemic stroke through suppression of inflammation[J]. Peptides, 2015, 63: 55-62.
[17] Zou Y, Wang B, Fu W, et al. Apelin-13 protects PC12 cells from Corticosterone-Induced apoptosis through PI3K and ERKs activation[J]. Neurochem Res, 2016, 41(7): 1635-1644.
[18] Wu F, Qiu J, Fan Y, et al. Apelin-13 attenuates ER stress-mediated neuronal apoptosis by activating Gα(i)/Gα(q)-CK2 signaling in ischemic stroke[J]. Exp Neurol, 2018, 302: 136-144.
[19] Huang CY, Dai CF, Gong K, et al. Apelin-13 protects neurovascular unit against ischemic injuries through the effects of vascular endothelial growth factor[J]. Neuropeptides, 2016, 60: 67-74.
[20] Sanchez A, Wadhwani S, Grammas P. Multiple neurotrophic effects of VEGF on cultured neurons[J]. Neuropeptides, 2010, 44(4):323-331.
[21] Chen D, Lee J, Gu X, et al. Intranasal delivery of apelin-13 is neuroprotective and promotes angiogenesis after ischemic stroke in mice[J]. ASN Neuro, 2015, 7(5): 1759091415605114.
[22] Khaksari M, Aboutaleb N, Nasirinezhad FA, et al. Apelin-13 protects the brain against ischemic reperfusion injury and cerebral edema in a transient model of focal cerebral ischemia[J]. Journal of Molecular Neuroscience, 2012, 48(1): 201-208.
[23] Chu H, Yang X, Huang C, et al. Apelin-13 protects against ischemic Blood-Brain barrier damage through the effects of aquaporin-4[J]. Cerebrovasc Dis, 2017, 44(1/2): 10-25.
[24] Bircan B, ?kr M, Krba(ˇoverg)S, et al. Effect of apelin hormone on renal ischemia/reperfusion induced oxidative damage in rats[J]. Ren Fail, 2016, 38(7): 1122-1128.
[25] Duan JL, Jia C, Yang ZF, et al. Neuroprotective effect of Apelin 13 on ischemic stroke by activating AMPK/GSK-3β/Nrf2 signaling[J]. J Neuroinflammation, 2019, 16(1): 30709405.
[26] Foroughi K, Khaksari M, Rahmati M, et al. Apelin-13 protects PC12 cells against Methamphetamine-Induced oxidative stress, autophagy and apoptosis[J]. Neurochem Res, 2019, 44(9): 2103-2112.
[27] Ban JY, Cho SO, Choi SH, et al. Neuroprotective effect of Smilacis chinae rhizome on NMDA-induced neurotoxicity in vitro and focal cerebral ischemia in vivo[J]. J Pharmacol Sci, 2008, 106(1): 68-77.
[28] O’Donnell LA, Agrawal A, Sabnekar P, et al. Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury[J]. J Neurochem, 2007, 102(6):1905-1917.
[29] Zeng XJ, Yu SP, Zhang L, et al. Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons[J]. Exp Cell Res, 2010, 316(11): 1773-1783.
[30] Tabas I, García-Carde? G, Owens GK. Recent insights into the cellular biology of atherosclerosis[J]. J Cell Biol, 2015, 209(1): 13-22.
[31] Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis[J]. Circ Res, 2016, 118(4): 692-702.
[32] Zhang C, Chen D, Maguire EM, et al. Cbx3 inhibits vascular smooth muscle cell proliferation, migration, and neointima formation[J]. Cardiovasc Res, 2018, 114(3): 443-455.
[33] Moreno PR. Vulnerable plaque: definition, diagnosis, and treatment[J]. Cardiol Clin, 2010, 28(1): 1-30.
[34] Fraga-Silva RA, Seeman H, Montecucco F, et al. Apelin-13 treatment enhances the stability of atherosclerotic plaques[J]. Cardiovasc Res, 2016, 111(1): S107.
[35] Wang X, Tian X, Pei LL, et al. The association between serum apelin-13 and the prognosis of acute ischemic stroke[J]. Transl Stroke Res, 2020, 11(4): 700-707.